Latest Period
Q1 2026
Security Snapshot
Biohaven Ltd. - Common Shares (BHVN) Institutional Ownership
CUSIP: G1110E107
13F Institutional Holders and Ownership History from Q2 2022 to Q2 2026
Institutions Reporting
275
Shares (Excl. Options)
141,967,535
Price
$8.46
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- BHVN on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 141,967,535
- Total 13F value
- $1,201,449,395
- Portfolio coverage rank
- 0%
- Share change
- +22,901,392
- Value change
- +$181,233,334
- Number of holders
- 275
- Shares outstanding
- 150,608,351
- SEC-reported price per share
- $15.76
- Insider filing price
- $15.76
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BHVN - Biohaven Ltd. - Common Shares is tracked under CUSIP G1110E107.
- 275 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 275 to 78 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,201,449,395 to $81,726,054.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 275 institutions filings for Q1 2026.
Security key
G1110E107
Latest holder period
Q1 2026
13F holders
275
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
BHVN full holder history
Biohaven Ltd. SEC filings
Biohaven Ltd. company facts
Biohaven Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G1110E107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
BHVN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.8% | $116,139,519 | 10,286,937 | SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec 2025 | |||
| Janus Henderson Group Ltd. | 5.7% | -50% | $127,742,554 | -$133,177,733 | 8,584,676 | -51% | JANUS HENDERSON GROUP Ltd. | 30 Jun 2026 |
| VANGUARD GROUP INC | 2.7% | $43,156,602 | 2,875,190 | The Vanguard Group | 30 Sep 2025 |
As of 31 Mar 2026, 275 institutional investors reported holding 141,967,535 shares of Biohaven Ltd. - Common Shares (BHVN). This represents 94% of the company’s total 150,608,351 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | 17,534,612 | +1146% | 0.07% | $148,213,808 |
| BlackRock, Inc. | 7.5% | 11,222,407 | +19% | 0% | $94,941,564 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.8% | 10,286,937 | 0% | 2.4% | $87,027,487 |
| STIFEL FINANCIAL CORP | 6.6% | 9,940,885 | +0.01% | 0.08% | $84,099,886 |
| STATE STREET CORP | 4.4% | 6,618,803 | +16% | 0% | $55,995,073 |
| INFINITUM ASSET MANAGEMENT, LLC | 4.1% | 6,250,000 | 0% | 6.6% | $52,875,000 |
| TCG Crossover Management, LLC | 3.1% | 4,631,317 | 0% | 1.1% | $39,180,942 |
| Royalty Pharma Sub-Manager, LLC | 1.9% | 2,936,507 | 0% | 14% | $24,842,849 |
| D. E. Shaw & Co., Inc. | 1.9% | 2,847,193 | +5.7% | 0.02% | $24,087,253 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 2,767,763 | +16% | 0% | $23,420,018 |
| GOLDMAN SACHS GROUP INC | 1.7% | 2,513,181 | +28% | 0% | $21,261,511 |
| Balyasny Asset Management L.P. | 1.6% | 2,445,416 | +54% | 0.04% | $20,688,219 |
| FMR LLC | 1.6% | 2,359,047 | -12% | 0% | $19,957,541 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5% | 2,279,275 | 0% | 0% | $19,282,667 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.5% | 2,217,175 | +9.8% | 0% | $18,758,000 |
| AQR CAPITAL MANAGEMENT LLC | 1.3% | 1,975,516 | +35% | 0.01% | $16,712,862 |
| Cormorant Asset Management, LP | 1.2% | 1,760,000 | +17500% | 0.75% | $14,889,600 |
| CITADEL ADVISORS LLC | 1.1% | 1,723,107 | -1.2% | 0.01% | $14,577,485 |
| STEMPOINT CAPITAL LP | 1.1% | 1,594,491 | 2.6% | $13,489,394 | |
| BNP PARIBAS FINANCIAL MARKETS | 1% | 1,544,338 | 0% | 0.01% | $13,065,099 |
| Qube Research & Technologies Ltd | 1% | 1,540,445 | -1.9% | 0.02% | $13,032,165 |
| ExodusPoint Capital Management, LP | 1% | 1,501,099 | +26% | 0.13% | $12,699,298 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.99% | 1,497,793 | +899% | 0.02% | $12,671,329 |
| MILLENNIUM MANAGEMENT LLC | 0.96% | 1,447,886 | +9.3% | 0.01% | $12,249,116 |
| UBS Group AG | 0.95% | 1,426,427 | +20% | 0% | $12,067,572 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
17
Latest
Q1 2026
Rows shown
1-17 of 17
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 5,496,500 | $81,726,054 | +$2,085,410 | $14.88 | 78 |
| 2026 Q1 | 141,967,535 | $1,201,449,395 | +$181,233,334 | $8.46 | 275 |
| 2025 Q4 | 121,437,146 | $1,371,219,974 | +$339,162,643 | $11.29 | 271 |
| 2025 Q3 | 84,320,326 | $1,263,904,622 | -$38,241,337 | $15.01 | 261 |
| 2025 Q2 | 86,987,421 | $1,227,652,713 | -$143,894,992 | $14.11 | 247 |
| 2025 Q1 | 88,106,650 | $2,142,495,070 | -$115,214,537 | $24.04 | 260 |
| 2024 Q4 | 89,346,784 | $3,336,885,126 | +$168,942,579 | $37.35 | 253 |
| 2024 Q3 | 86,165,783 | $4,306,353,110 | +$148,383,281 | $49.97 | 250 |
| 2024 Q2 | 82,422,187 | $2,860,885,986 | +$210,746,356 | $34.71 | 222 |
| 2024 Q1 | 74,154,350 | $4,055,673,624 | +$161,363,053 | $54.69 | 239 |
| 2023 Q4 | 71,802,540 | $3,073,238,412 | +$434,075,584 | $42.80 | 214 |
| 2023 Q3 | 61,463,892 | $1,598,669,852 | +$39,755,212 | $26.01 | 183 |
| 2023 Q2 | 60,120,418 | $1,438,087,383 | -$122,838,089 | $23.92 | 183 |
| 2023 Q1 | 66,543,203 | $909,962,550 | +$54,642,668 | $13.66 | 171 |
| 2022 Q4 | 62,449,262 | $868,331,200 | +$266,710,670 | $13.88 | 168 |
| 2022 Q3 | 3,316,172 | $499,083,000 | +$491,524,000 | $151.17 | 29 |
| 2022 Q2 | $23.92 | 0 |